Corvex Gross Profit decreased by 372.5% to -$945.00K in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 107.2%, from -$456.00K to -$945.00K. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved manufacturing efficiency, favorable product mix, or higher pricing power, while a decrease may indicate rising raw material costs, supply chain inefficiencies, or competitive pricing pressure.
Gross profit represents the residual earnings a company retains after deducting the direct costs associated with produci...
Peers in the medical device and diagnostics sector typically maintain high gross margins due to intellectual property and specialized manufacturing, though these vary based on the specific product mix of nutritionals versus high-tech devices.
gross_profit| Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|
| Value | -$363.00K | -$357.00K | -$795.00K | -$456.00K | -$436.00K | -$259.00K | -$200.00K | -$945.00K |
| QoQ Change | — | +1.7% | -122.7% | +42.6% | +4.4% | +40.6% | +22.8% | -372.5% |
| YoY Change | — | — | — | — | -20.1% | +27.5% | +74.8% | -107.2% |